Scopolammonium, N-methylbromide
Brand names,
Scopolammonium, N-methylbromide
Analogs
Scopolammonium, N-methylbromide
Brand Names Mixture
- Biosol-M-Aquadrops liq (methscopolamine bromide + neomycin sulfate)
- Neomix-pamine Scour Bolus (methscopolamine bromide + neomycin sulfate)
- Neomix-pamine Solution (methscopolamine bromide + neomycin sulfate)
- Neosol M Aquadrops (methscopolamine bromide + neomycin)
- Scour solution (methscopolamine bromide + neomycin)
- Scour solution coop (methscopolamine bromide + neomycin)
Scopolammonium, N-methylbromide
Chemical_Formula
C18H24NO4.Br
Scopolammonium, N-methylbromide
RX_link
http://www.rxlist.com/cgi/pharmclips2.cgi?keyword=%20Methscopolamine
Scopolammonium, N-methylbromide
fda sheet
Scopolammonium, N-methylbromide
msds (material safety sheet)
Scopolammonium, N-methylbromide
Synthesis Reference
No information avaliable
Scopolammonium, N-methylbromide
Molecular Weight
397.089 g/mol
Scopolammonium, N-methylbromide
Melting Point
225 oC
Scopolammonium, N-methylbromide
H2O Solubility
Freely soluble
Scopolammonium, N-methylbromide
State
Solid
Scopolammonium, N-methylbromide
LogP
-2.58
Scopolammonium, N-methylbromide
Dosage Forms
Tablet (2.5mg, 5mg)
Scopolammonium, N-methylbromide
Indication
Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.
Scopolammonium, N-methylbromide
Pharmacology
Methscopolamine bromide is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Methscopolamine bromide has many uses including the prevention of motion sickness. It is not clear how methscopolamine bromide prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that methscopolamine bromide prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Methscopolamine bromide also may work directly on the vomiting center. Methscopolamine bromide must be taken before the onset of motion sickness to be effective.
Scopolammonium, N-methylbromide
Absorption
Poorly and unreliably absorbed, total absorption is 10-25%.
Scopolammonium, N-methylbromide
side effects and Toxicity
Symptoms of a methscopolamine bromide overdose include headache, nausea, vomiting, dry mouth, difficulty swallowing, blurred vision, dilated pupils, hot, dry skin, dizziness; drowsiness, confusion, anxiety, seizures, weak pulse, and an irregular heartbeat. In addition, a curare-like action may occur, i.e., neuromuscular blockade leading to muscular weakness and possible paralysis.
Scopolammonium, N-methylbromide
Patient Information
No information avaliable
Scopolammonium, N-methylbromide
Organisms Affected
Humans and other mammals